首页 工具
登录

搜索结果

Search Results for "RHI002-Me"

1

抑制剂 & 化合物

128

化合物库

4

TargetMol 试剂盒

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

Cat. No. Product Name
CL0091 MEK inhibitor kit

CL0089 c-Met/HGFR inhibitor kit

L6210 藏药化合物库

754 compounds
A collection of 754 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.
L2530 小鼠代谢化合物库

224 compounds
A unique collection of 224 mouse metabolites, which can be used for HTS and HCS;
L1010 FDA上市及药典收录分子库

3158 compounds
3158个上市及药典分子集合,可用于高通量筛选和高内涵筛选;
L1600 激酶抑制剂库

2230 compounds
A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases;
L2192 抗胰腺癌化合物库

2267 compounds
A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS;
L5400 抗心血管疾病化合物库

1428 compounds
A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L1000 上市药物库

2863 compounds
A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS);
L9100 磷酸酶抑制剂化合物库

80 compounds
A collection of 80 phosphatase inhibitors with known activity;
L8000 干细胞分化化合物库

1213 compounds
A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening;
CL0109 Ras inhibitor kit

L1100 蛋白酶抑制剂库

344 compounds
A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening;
L2521 糖酵解化合物库

560 compounds
560 glycolysis-related active compounds for high-throughput and high-content screening.
L1200 表观遗传库

960 compounds
Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L1720 核苷类化合物库

337 compounds
A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;
L6300 药食同源库

1088 compounds
A unique collection of 1088 compounds from food as medicine for high throughput and high content screening;
L9500 表型筛选靶点鉴定库

1832 compounds
A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening;
L6030 天然产物衍生物虚筛化合物库

L8110 细胞重编程化合物库

1840 compounds
A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L2540 肠道微生物代谢化合物库

352 compounds
A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS;
L7400 钠通道分子库

128 compounds
A unique collection of 128 sodium channel blockers and agonists for high throughput and high content screening;
L2600 神经信号分子库

2011 compounds
A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L5610 Golden骨架库

10000 compounds
Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source;
L9610 环肽库

58 compounds
58 species of cyclic peptide molecules for high-throughput and high-content screening;
L4900 心血管毒性化合物库

127 compounds
A unique collection of 127 cardiotoxicity inducing compounds for toxicological study;
L7810 高溶解性多官能团片段化合物库

1159 compounds
Highly soluble multifunctional fragment library contains 1159 kinds of fragment molecules.
L9700 内质网应激化合物库

193 compounds
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS);
L3600 细胞因子抑制剂库

613 compounds
A unique collection of 613 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;
L7840 高溶解性卤化片段化合物库

796 compounds
The highly soluble halogenated fragment library contains 796 halogenated fragment compounds.
L9200 药物功能重定位化合物库

4240 compounds
A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);
L7000 活性脂质化合物库

385 compounds
A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa
L9850 口服活性化合物库

2484 compounds
A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening.
L9820 β-内酰胺类化合物库

105 compounds
A unique collection of 105 beta-lactam compounds, can be used in HTS and HCS;
L4800 血管生成库

1370 compounds
A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
L2800 5-羟色胺分子库

275 compounds
A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening;
L8300 染色质修饰分子库

256 compounds
A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS);
L8100 细胞周期化合物库

695 compounds
A unique collection of 695 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);
L2510 脂代谢化合物库

496 compounds
A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).
L9600 多肽分子库

533 compounds
533 peptides can be used in peptide drug development and signaling transduction and mechanism study;
L6220 蒙药化合物库

960 compounds
A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening.
L9830 抗帕金森病化合物库

908 compounds
A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.
L6610 抗感染天然产物库

1070 compounds
A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS);
L8500 HIF-1化合物库

1352 compounds
A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies;
L7600 趋化因子抑制剂库

59 compounds
A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;
L7700 神经再生化合物库

529 compounds
A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening;
L9000 细胞凋亡化合物库

1796 compounds
A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;
L2130 抗癌细胞代谢库

1280 compounds
A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
L7900 成骨分子库

320 compounds
A unique collection of 320 osteogenesis related compounds for high throughput and high content screening;
L8720 细胞焦亡化合物库

1077 compounds
1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening.
L1610 FDA 上市激酶抑制剂库

280 compounds
Targetmol’s FDA-Approved Kinase Inhibitor Library contains 280 marketed drugs with proven kinase inhibitory activity. These kinases include Insulin/IGF Receptors、PI 3-Kinase、CaM Kinase II、JAK、PKA、CDK、JNK、PKC、CKI II、MAPK、RAF、EGFR、MEK、SAPK、GSK、MLCK、Src-family、IKK、PDGFR、VEGFR etc. FDA-Approved Kinase Inhibitor Library is a powerful tool for kinase drug development and related research.
L2194 抗结直肠癌化合物库

1565 compounds
1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.
L6620 抗寄生虫天然产物库

233 compounds
A unique collection of 233 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS);
L6900 稀有天然产物库

284 compounds
A unique collection of 284 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);
L8710 铜死亡化合物库

411 compounds
TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases.
L3900 DNA 损伤和修复分子库

937 compounds
A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS);
L7100 抗肥胖化合物库

1359 compounds
A unique collection of 1359 anti-obesity compounds for high throughput and high content screening;
L2195 抗前列腺癌化合物库

2096 compounds
2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.
L9860 抗抑郁症化合物库

1181 compounds
1181 compounds associated with depression that can be used for high-throughput and high-content screening
L2910 抗氧化化合物库

1040 compounds
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of a...
L3510 甲基化化合物库

131 compounds
131 methylation-related compounds that can be used for high-throughput and high-content screening.
L6110 生物碱类天然产物库

468 compounds
A unique collection of 468 natural alkaloids can be used for high throughput and high content screening;
L1510 核受体化合物库

420 compounds
A unique collection of 420 nuclear receptor signaling targeted compounds for high throughput and high content screening;
L5800 药物代谢杂质库

200 compounds
A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);
L4400 抗生素库

708 compounds
A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening;
L9400 PPI抑制剂库

260 compounds
A unique collection of 260 PPI-related compounds for drug screening;
L2000 抑制剂库

7618 compounds
A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L2191 抗乳腺癌化合物库

1965 compounds
A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study;
L2193 抗肝癌化合物库

1816 compounds
1816 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.
L1110 微管靶向化合物库

80 compounds
A unique collection of 80 microtubule-targeted compounds can be used in HTS and HCS;
L6020 天然产物单体化合物库

L3980 DNA损伤/修复库Plus

667 compounds
Well-chosen 667 compounds with unique structures targeting DNA damage & repair;
L1400 MAPK 抑制剂库

367 compounds
A unique collection of 367 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;
L4710 非甾体类抗炎化合物库

530 compounds
530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.
L2200 酪氨酸激酶分子库

746 compounds
A unique collection of 746 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;
L3500 组蛋白修饰化合物库

362 compounds
A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);
L2400 内分泌激素分子库

813 compounds
A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L6120 黄酮类天然产物库

477 compounds
A unique collection of 477 flavonoids can be used for high throughput and high content screening;
L2610 神经递质受体化合物库

1513 compounds
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening;
L1310 细胞骨架化合物库

590 compounds
A unique collection of 590 cytoskeleton-related compounds, can be used for HTS and HCS;
L2150 抗癌药物库

2900 compounds
A unique collection of 2900 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);
L2300 离子通道库

946 compounds
A unique collection of 946 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;
L2160 抗癌活性化合物库

2439 compounds
A unique collection of 2439 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L2100 抗癌化合物库

6854 compounds
A unique collection of 6854 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L2120 抗癌临床化合物库

2359 compounds
A unique collection of 2359 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);
L5900 血脑屏障通透化合物库

516 compounds
A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);
L4100 TGF-β/Smad靶点化合物库

180 compounds
A unique collection of 180 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;
L2110 抗癌上市药物库

1806 compounds
A unique collection of 1806 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);
L3700 JAK-STAT 化合物库

256 compounds
A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening;
L1120 AMPK靶向分子库

64 compounds
64 well-chosen unique AMPK-targeted small molecules;
L2190 抗肺癌化合物库

1735 compounds
A unique collection of 1735 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study;
DP9200 DGK抑制剂库

L9230 ReFRAME 相关化合物库

3274 compounds
A unique collection of 3274 compounds for high-throughput screening and high-content screening,
L9210 儿童药物库

1015 compounds
A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening.
L7500 凝血与抗凝化合物库

154 compounds
A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS);
L2500 人内源代谢化合物库

1400 compounds
A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening;
L2140 癌细胞分化化合物库

413 compounds
A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening;
L8400 血液病分子库

524 compounds
A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);
L4010 已知活性化合物库

20980 compounds
A collection of 20980 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.
L1300 PI3K/Akt/mTOR 化合物库

425 compounds
A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;
L7200 钙通道分子库

143 compounds
A unique collection of 143 calcium channel blockers and agonists for high throughput and high content screening;
L9840 抗阿尔茨海默症化合物库

1040 compounds
A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.
L6200 瑶药化合物库

225 compounds
A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening.
L4300 Wnt/Hedgehog/Notch 通路化合物库

240 compounds
A unique collection of 240 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;
L4700 免疫/炎症分子化合物库

3483 compounds
A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening.
L5300 线粒体靶向库

447 compounds
A unique collection of 447 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;
L5700 精选片段库

246 compounds
A unique collection of 246 fragment-like small molecules for FBDD;
L3800 NF-κB 通路分子库

560 compounds
A unique collection of 560 compounds targeting NF-κB signaling for high throughput screening and high content screening;
L4600 植物来源化合物库

3076 compounds
A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);
L2152 靶向治疗药物库

121 compounds
121 tumor-targeted drugs that can be used for high-throughput and high-content screening.
L2151 化疗药物库

51 compounds
51 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.
L6800 中国药典收录天然产物库

2070 compounds
A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;
L2620 神经退行性疾病化合物库

1622 compounds
A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS;
L9810 抗纤维化化合物库

1180 compounds
A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS;
L2550 谷氨酰胺代谢化合物库

580 compounds
A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;
L1710 抗COVID-19化合物库

1160 compounds
A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents;
L6500 微生物天然产物库

254 compounds
254种微生物来源的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选;
L6130 萜类天然产物库

349 compounds
A unique collection of 349 natural terpenes and terpenoids can be used for high throughput and high content screening;
L8600 泛素化化合物库

214 compounds
A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening;
L6140 糖类及苷类化合物库

364 compounds
A unique collection of 364 saccharides and glycosides compounds can be used for HTS and HCS;
L5100 含氟化合物库

583 compounds
A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);
L5510 肝脏毒性化合物库

1040 compounds
A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening;
L2520 糖代谢化合物库

708 compounds
708 glycometabolism-related comounds, can be used for HTS and HCT;
L6000 高通量筛选天然产物库

4320 compounds
A unique collection of 4320 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen
L9420 外泌体相关化合物库

54 compounds
54 exosome-related compounds that can be used for high-throughput and high-content screening.
L2170 肿瘤免疫治疗小分子化合物库

454 compounds
A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening;
L6720 抗COVID-19中药单体库

1162 compounds
A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening;
L9410 共价抑制剂库

941 compounds
A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc.

化合物库

MEK inhibitor kit
CL0091
Compounds: 0
c-Met/HGFR inhibitor kit
CL0089
Compounds: 0
藏药化合物库
L6210
Compounds: 754
小鼠代谢化合物库
L2530
Compounds: 224
FDA上市及药典收录分子库
L1010
Compounds: 3158
激酶抑制剂库
L1600
Compounds: 2230
抗胰腺癌化合物库
L2192
Compounds: 2267
抗心血管疾病化合物库
L5400
Compounds: 1428
上市药物库
L1000
Compounds: 2863
磷酸酶抑制剂化合物库
L9100
Compounds: 80
干细胞分化化合物库
L8000
Compounds: 1213
Ras inhibitor kit
CL0109
Compounds: 0
蛋白酶抑制剂库
L1100
Compounds: 344
糖酵解化合物库
L2521
Compounds: 560
表观遗传库
L1200
Compounds: 960
核苷类化合物库
L1720
Compounds: 337
药食同源库
L6300
Compounds: 1088
表型筛选靶点鉴定库
L9500
Compounds: 1832
天然产物衍生物虚筛化合物库
L6030
Compounds: 0
细胞重编程化合物库
L8110
Compounds: 1840
肠道微生物代谢化合物库
L2540
Compounds: 352
钠通道分子库
L7400
Compounds: 128
神经信号分子库
L2600
Compounds: 2011
Golden骨架库
L5610
Compounds: 10000
环肽库
L9610
Compounds: 58
心血管毒性化合物库
L4900
Compounds: 127
高溶解性多官能团片段化合物库
L7810
Compounds: 1159
内质网应激化合物库
L9700
Compounds: 193
细胞因子抑制剂库
L3600
Compounds: 613
高溶解性卤化片段化合物库
L7840
Compounds: 796
药物功能重定位化合物库
L9200
Compounds: 4240
活性脂质化合物库
L7000
Compounds: 385
口服活性化合物库
L9850
Compounds: 2484
β-内酰胺类化合物库
L9820
Compounds: 105
血管生成库
L4800
Compounds: 1370
5-羟色胺分子库
L2800
Compounds: 275
染色质修饰分子库
L8300
Compounds: 256
细胞周期化合物库
L8100
Compounds: 695
脂代谢化合物库
L2510
Compounds: 496
多肽分子库
L9600
Compounds: 533
蒙药化合物库
L6220
Compounds: 960
抗帕金森病化合物库
L9830
Compounds: 908
抗感染天然产物库
L6610
Compounds: 1070
HIF-1化合物库
L8500
Compounds: 1352
趋化因子抑制剂库
L7600
Compounds: 59
神经再生化合物库
L7700
Compounds: 529
细胞凋亡化合物库
L9000
Compounds: 1796
抗癌细胞代谢库
L2130
Compounds: 1280
成骨分子库
L7900
Compounds: 320
细胞焦亡化合物库
L8720
Compounds: 1077
FDA 上市激酶抑制剂库
L1610
Compounds: 280
抗结直肠癌化合物库
L2194
Compounds: 1565
抗寄生虫天然产物库
L6620
Compounds: 233
稀有天然产物库
L6900
Compounds: 284
铜死亡化合物库
L8710
Compounds: 411
DNA 损伤和修复分子库
L3900
Compounds: 937
抗肥胖化合物库
L7100
Compounds: 1359
抗前列腺癌化合物库
L2195
Compounds: 2096
抗抑郁症化合物库
L9860
Compounds: 1181
抗氧化化合物库
L2910
Compounds: 1040
甲基化化合物库
L3510
Compounds: 131
生物碱类天然产物库
L6110
Compounds: 468
核受体化合物库
L1510
Compounds: 420
药物代谢杂质库
L5800
Compounds: 200
抗生素库
L4400
Compounds: 708
PPI抑制剂库
L9400
Compounds: 260
抑制剂库
L2000
Compounds: 7618
抗乳腺癌化合物库
L2191
Compounds: 1965
抗肝癌化合物库
L2193
Compounds: 1816
微管靶向化合物库
L1110
Compounds: 80
天然产物单体化合物库
L6020
Compounds: 0
DNA损伤/修复库Plus
L3980
Compounds: 667
MAPK 抑制剂库
L1400
Compounds: 367
非甾体类抗炎化合物库
L4710
Compounds: 530
酪氨酸激酶分子库
L2200
Compounds: 746
组蛋白修饰化合物库
L3500
Compounds: 362
内分泌激素分子库
L2400
Compounds: 813
黄酮类天然产物库
L6120
Compounds: 477
神经递质受体化合物库
L2610
Compounds: 1513
细胞骨架化合物库
L1310
Compounds: 590
抗癌药物库
L2150
Compounds: 2900
离子通道库
L2300
Compounds: 946
抗癌活性化合物库
L2160
Compounds: 2439
抗癌化合物库
L2100
Compounds: 6854
抗癌临床化合物库
L2120
Compounds: 2359
血脑屏障通透化合物库
L5900
Compounds: 516
TGF-β/Smad靶点化合物库
L4100
Compounds: 180
抗癌上市药物库
L2110
Compounds: 1806
JAK-STAT 化合物库
L3700
Compounds: 256
AMPK靶向分子库
L1120
Compounds: 64
抗肺癌化合物库
L2190
Compounds: 1735
DGK抑制剂库
DP9200
Compounds: 0
ReFRAME 相关化合物库
L9230
Compounds: 3274
儿童药物库
L9210
Compounds: 1015
凝血与抗凝化合物库
L7500
Compounds: 154
人内源代谢化合物库
L2500
Compounds: 1400
癌细胞分化化合物库
L2140
Compounds: 413
血液病分子库
L8400
Compounds: 524
已知活性化合物库
L4010
Compounds: 20980
PI3K/Akt/mTOR 化合物库
L1300
Compounds: 425
钙通道分子库
L7200
Compounds: 143
抗阿尔茨海默症化合物库
L9840
Compounds: 1040
瑶药化合物库
L6200
Compounds: 225
Wnt/Hedgehog/Notch 通路化合物库
L4300
Compounds: 240
免疫/炎症分子化合物库
L4700
Compounds: 3483
线粒体靶向库
L5300
Compounds: 447
精选片段库
L5700
Compounds: 246
NF-κB 通路分子库
L3800
Compounds: 560
植物来源化合物库
L4600
Compounds: 3076
靶向治疗药物库
L2152
Compounds: 121
化疗药物库
L2151
Compounds: 51
中国药典收录天然产物库
L6800
Compounds: 2070
神经退行性疾病化合物库
L2620
Compounds: 1622
抗纤维化化合物库
L9810
Compounds: 1180
谷氨酰胺代谢化合物库
L2550
Compounds: 580
抗COVID-19化合物库
L1710
Compounds: 1160
微生物天然产物库
L6500
Compounds: 254
萜类天然产物库
L6130
Compounds: 349
泛素化化合物库
L8600
Compounds: 214
糖类及苷类化合物库
L6140
Compounds: 364
含氟化合物库
L5100
Compounds: 583
肝脏毒性化合物库
L5510
Compounds: 1040
糖代谢化合物库
L2520
Compounds: 708
高通量筛选天然产物库
L6000
Compounds: 4320
外泌体相关化合物库
L9420
Compounds: 54
肿瘤免疫治疗小分子化合物库
L2170
Compounds: 454
抗COVID-19中药单体库
L6720
Compounds: 1162
共价抑制剂库
L9410
Compounds: 941
Cat. No. Product Name Form Specificity Of Inhibition
C0004 Phosphatase Inhibitor Cocktail III (2 Tubes, 100x)

磷酸酶抑制剂 Cocktail III

2 Tube Solution (100×) Each Tube has different specificity of inhibition
C0003 Phosphatase Inhibitor Cocktail II (100× DMSO)

磷酸酶抑制剂 Cocktail II

Solution (100× in DMSO) Alkaline phosphatases, Ser/Thr phosphatases, Acid and PP1 and PP2A
C0002 Phosphatase Inhibitor Cocktail I (100× ddH2O)

磷酸酶抑制剂 Cocktail I

Solution (100× in ddH2O) Acid Phosphatase, Alkaline phosphatase, PTPs, ATPases
C0045 RIPA Lysis Buffer (Strong)

RIPA Lysis Buffer (Strong)

TargetMol 试剂盒

磷酸酶抑制剂 Cocktail III
C0004
磷酸酶抑制剂 Cocktail II
C0003
磷酸酶抑制剂 Cocktail I
C0002
RIPA Lysis Buffer (Strong)
C0045
Cat. No. Product Name Target Signaling Pathways
T28535 RHI002-Me

RHI002-Me is a methylated derivative of RHI002, a selective inhibitor of human RNaseH2.

化合物

RHI002-Me
T28535
synonym:
Target: